UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 93

Sortiert nach

Acute effects of insulin and insulin‐induced hypoglycaemia on carotid body chemoreceptor activity and cardiorespiratory responses in dogs

Experimental physiology, 2023-02, Vol.108 (2), p.280-295

2023

Volltextzugriff (PDF)

Splenic arterial neurovascular bundle stimulation in esophagectomy: A feasibility and safety prospective cohort study

Frontiers in neuroscience, 2022-12, Vol.16, p.1088628-1088628

2022

Volltextzugriff (PDF)

Differences in Effects on Myocardium and Mitochondria by Angiogenic Inhibitors Suggest Separate Mechanisms of Cardiotoxicity

Toxicologic pathology, 2010-08, Vol.38 (5), p.691-702

2010

Volltextzugriff (PDF)

Differential effects of p38 mitogen-activated protein kinase and cyclooxygenase 2 inhibitors in a model of cardiovascular disease

The Journal of pharmacology and experimental therapeutics, 2009-09, Vol.330 (3), p.964

2009

Volltextzugriff (PDF)

Comparison of soluble guanylate cyclase stimulators and activators in models of cardiovascular disease associated with oxidative stress

Frontiers in pharmacology, 2012-01, Vol.3, p.128-128

2012

Volltextzugriff (PDF)

Effects of p38 MAPK Inhibitor on Angiotensin II-Dependent Hypertension, Organ Damage, and Superoxide Anion Production

Journal of cardiovascular pharmacology, 2007-06, Vol.49 (6), p.362-368

2007

Volltextzugriff (PDF)

Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase-dependent in a rat model of cardiac hypertrophy and dysfunction

Circulation (New York, N.Y.), 2001-09, Vol.104 (11), p.1292-1298

2001

Volltextzugriff (PDF)

Alpha-1 Acid Glycoprotein as a Biomarker for Subclinical Illness and Altered Drug Binding in Rats

Comparative medicine, 2021-04, Vol.71 (2), p.123-132

2021

Volltextzugriff (PDF)

Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in hypertensive heart disease

Journal of hypertension, 2004-03, Vol.22 (3), p.583-592

2004

Volltextzugriff (PDF)

Carvedilol Prevents and Reverses Hypertrophy-Induced Cardiac Dysfunction

Pharmacology, 2007-01, Vol.80 (2-3), p.166-176

2007

Volltextzugriff (PDF)

Urodynamic Measurements by Radiotelemetry in Conscious, Freely Moving Beagle Dogs

The Journal of urology, 2009-03, Vol.181 (3), p.1444-1451

2009

Volltextzugriff (PDF)

A novel method for chronic measurement of respiratory function in the conscious monkey

Journal of pharmacological and toxicological methods, 2001-07, Vol.46 (1), p.13-20

2001

Volltextzugriff (PDF)

Continuing Education Course #1: Non-Invasive Imaging as a Problem-Solving Tool and Translational Biomarker Strategy in Toxicologic Pathology

Toxicologic Pathology, 2011-01, Vol.39 (1), p.267-272

2011

Volltextzugriff (PDF)

Echocardiography in non-clinical safety studies: adding value, and increasing acceptance and application

Toxicology letters, 2013-08, Vol.221, p.S50-S51

Coatney, Robert W.

2013

Volltextzugriff (PDF)

Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection

Cardiovascular research, 2005-04, Vol.66 (1), p.170

2005

Volltextzugriff (PDF)

Deletion of the UT receptor gene results in the selective loss of urotensin‐II contractile activity in aortae isolated from UT receptor knockout mice

British journal of pharmacology, 2003-05, Vol.139 (2), p.464-472

2003

Volltextzugriff (PDF)

Eprosartan reduces cardiac hypertrophy, protects heart and kidney, and prevents early mortality in severely hypertensive stroke-prone rats

Cardiovascular research, 2001-06, Vol.50 (3), p.525-537

2001

Volltextzugriff (PDF)

Applications of micro-CT and MR microscopy to study pre-clinical models of osteoporosis and osteoarthritis

Technology and health care, 1998-12, Vol.6 (5-6), p.361

1998

Volltextzugriff (PDF)

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

Nature (London), 1999-09, Vol.401 (6750), p.282-286

1999

Volltextzugriff (PDF)

Human Urotensin-II is a Potent Vasoactive Peptide: Pharmacological Characterization in the Rat, Mouse, Dog and Primate

Journal of cardiovascular pharmacology, 2000, Vol.36 (5 Suppl 1), p.S163-S166

2000

Volltextzugriff (PDF)

Enrasentan Improves Survival, Limits Left Ventricular Remodeling, and Preserves Myocardial Performance in Hypertensive Cardiac Hypertrophy and Dysfunction

Journal of cardiovascular pharmacology, 2001-10, Vol.38 (4), p.606-617

2001

Volltextzugriff (PDF)

Application of serial in vivo magnetic resonance imaging to evaluate the efficacy of endothelin receptor antagonist SB 217242 in the rat carotid artery model of neointima formation

Circulation (New York, N.Y.), 1998-06, Vol.97 (22), p.2252-2258

1998

Volltextzugriff (PDF)

Longitudinal assessment of systolic and diastolic function using conventional and speckle tracking echocardiography following acute ischemia and prolonged reperfusion in the rat

The FASEB journal, 2013-04, Vol.27 (S1)

2013

Volltextzugriff (PDF)

Ultrasound Imaging: Principles and Applications in Rodent Research

ILAR journal, 2001, Vol.42 (3), p.233-247

Cootney, Robert W.

2001

Volltextzugriff (PDF)

A comparison of test article-induced changes in telemetry-based QA interval and left ventricular dP/dt to echocardiography endpoints in the conscious dog

Journal of pharmacological and toxicological methods, 2012-09, Vol.66 (2), p.195-195

2012

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(93)

Sprache

Englisch
(92)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(41)
Humans
(33)
Animals
(29)
Male
(20)
Malaria
(16)
Public, Environmental & Occupational Health
(15)
Rats
(15)
Tropical Medicine
(15)
Old Medline
(13)
Biological And Medical Sciences
(10)
Medical Sciences
(9)
Pharmacology & Pharmacy
(9)
Cardiovascular System & Cardiology
(8)
Malaria - Drug Therapy
(8)
Malaria, Vivax
(8)
Rats, Inbred Shr
(8)
Cardiac & Cardiovascular Systems
(7)
Antimalarials - Therapeutic Use
(6)
Dose-Response Relationship, Drug
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Acute effects of insulin and insulin‐induced hypoglycaemia on carotid body chemoreceptor activity and cardiorespiratory responses in dogs

Splenic arterial neurovascular bundle stimulation in esophagectomy: A feasibility and safety prospective cohort study

Differences in Effects on Myocardium and Mitochondria by Angiogenic Inhibitors Suggest Separate Mechanisms of Cardiotoxicity

Differential effects of p38 mitogen-activated protein kinase and cyclooxygenase 2 inhibitors in a model of cardiovascular disease

Comparison of soluble guanylate cyclase stimulators and activators in models of cardiovascular disease associated with oxidative stress

Effects of p38 MAPK Inhibitor on Angiotensin II-Dependent Hypertension, Organ Damage, and Superoxide Anion Production

Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase-dependent in a rat model of cardiac hypertrophy and dysfunction

Alpha-1 Acid Glycoprotein as a Biomarker for Subclinical Illness and Altered Drug Binding in Rats

Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in hypertensive heart disease

Carvedilol Prevents and Reverses Hypertrophy-Induced Cardiac Dysfunction

Urodynamic Measurements by Radiotelemetry in Conscious, Freely Moving Beagle Dogs

A novel method for chronic measurement of respiratory function in the conscious monkey

Continuing Education Course #1: Non-Invasive Imaging as a Problem-Solving Tool and Translational Biomarker Strategy in Toxicologic Pathology

Echocardiography in non-clinical safety studies: adding value, and increasing acceptance and application

Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection

Deletion of the UT receptor gene results in the selective loss of urotensin‐II contractile activity in aortae isolated from UT receptor knockout mice

Eprosartan reduces cardiac hypertrophy, protects heart and kidney, and prevents early mortality in severely hypertensive stroke-prone rats

Applications of micro-CT and MR microscopy to study pre-clinical models of osteoporosis and osteoarthritis

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

Human Urotensin-II is a Potent Vasoactive Peptide: Pharmacological Characterization in the Rat, Mouse, Dog and Primate

Enrasentan Improves Survival, Limits Left Ventricular Remodeling, and Preserves Myocardial Performance in Hypertensive Cardiac Hypertrophy and Dysfunction

Application of serial in vivo magnetic resonance imaging to evaluate the efficacy of endothelin receptor antagonist SB 217242 in the rat carotid artery model of neointima formation

Longitudinal assessment of systolic and diastolic function using conventional and speckle tracking echocardiography following acute ischemia and prolonged reperfusion in the rat

Ultrasound Imaging: Principles and Applications in Rodent Research

A comparison of test article-induced changes in telemetry-based QA interval and left ventricular dP/dt to echocardiography endpoints in the conscious dog

Suchergebnisse filtern